Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9800900 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL1456468 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL28292302 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL3660392 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| Cyclopentyl Palmitate SCHEMBL1457156 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL3654640 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| Cyclopentyl Heptadecanoate SCHEMBL27279720 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL16537767 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL1065817 | 0.98 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA | |
| SCHEMBL3660765 | 0.98 | NAAA (1.00) | NAAASMN1; SMN2DGKALMNAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180177798-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | ALLERGAN INC (US) | 2018-06-28 | — | — | US | claimed |
| US-20150328108-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | ALLERGAN INC (US) | 2015-11-19 | — | — | US | claimed |
| US-20140371320-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | ALLERGAN, INC. (US) | 2014-12-18 | — | — | US | claimed |
| US-20130011354-A1 | Compositions For Enhancing Hair Growth | ALLERGAN, INC. (US) | 2013-01-10 | — | — | US | claimed |
| US-20120322882-A1 | Compositions And Methods For Stimulating Hair Growth | ALLERGAN, INC. (US) | 2012-12-20 | — | — | US | claimed |
| CN-102724951-A | Compositions and methods for stimulating hair growth | ALLERGAN INC | 2012-10-10 | — | — | CN | claimed |
| EP-2498783-A2 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Allergan, Inc. (US) | 2012-09-19 | — | — | EP | claimed |
| EP-2498784-A2 | COMPOSITIONS FOR ENHANCING HAIR GROWTH | Allergan, Inc. (US) | 2012-09-19 | — | — | EP | claimed |
| US-8101161-B2 | Method of enhancing hair growth | ALLERGAN, INC. (US) | 2012-01-24 | — | — | US | claimed |
| US-20110124736-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | ALLERGAN, INC. (US) | 2011-05-26 | — | — | US | claimed |
| EP-2250996-A2 | Method of enhancing hair growth | ALLERGAN, INC. (US) | 2010-11-17 | — | — | EP | claimed |
| EP-2023769-A1 | EYELASH APPLICATOR AND METHOD | Allergan, Inc. (US) | 2009-02-18 | — | — | EP | claimed |
| US-7351404-B2 | Using a cyclopentane compound | ALLERGAN, INC. (US) | 2008-04-01 | — | — | US | claimed |
| US-20080041749-A1 | Re-closable vessel system for repeat administration of a drug product and method | ALLERGAN, INC. | 2008-02-21 | — | — | US | claimed |
| WO-2007143568-A1 | EYELASH APPLICATOR AND METHOD | ALLERGAN, INC. (US) | 2007-12-13 | — | — | WO | claimed |
| US-20070286890-A1 | Eyelash applicator and method | ALLERGAN, INC. | 2007-12-13 | — | — | US | claimed |
| US-20070282006-A1 | Method of enhancing hair growth | ALLERGAN, INC. | 2007-12-06 | — | — | US | claimed |
| EP-1471876-A1 | METHOD OF ENHANCING HAIR GROWTH | Allergan, Inc. (US) | 2004-11-03 | — | — | EP | claimed |
| WO-2003066008-A1 | METHOD OF ENHANCING HAIR GROWTH | ALLERGAN, INC. (US) | 2003-08-14 | — | — | WO | claimed |
| US-20030147823-A1 | Using a cyclopentane compound | ALLERGAN, INC. | 2003-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282006-A1 | Method of enhancing hair growth | FGF1, CYP21A2, HDGF | NAAA 1654/4885SMN1; SMN2 4397/4885DGKA 2974/4885 |
| US-20130011354-A1 | Compositions For Enhancing Hair Growth | FGF1, HDGF, FGF2 | NAAA 1319/4885SMN1; SMN2 4458/4885DGKA 1450/4885 |
| US-20120322882-A1 | Compositions And Methods For Stimulating Hair Growth | FGF1, HDGF, FGF2 | NAAA 1323/4885SMN1; SMN2 4698/4885DGKA 2069/4885 |
| US-20180177798-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | FGF1, HDGF, FGF2 | NAAA 1174/4885SMN1; SMN2 4657/4885DGKA 1963/4885 |
| US-20150328108-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | FGF1, HDGF, FGF2 | NAAA 1174/4885SMN1; SMN2 4657/4885DGKA 1963/4885 |
| US-20070286890-A1 | Eyelash applicator and method | SLC39A3, SLC39A11, GHRHR | NAAA 1432/4885SMN1; SMN2 4516/4885DGKA 2680/4885 |
| US-20140371320-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | FGF1, HDGF, FGF2 | NAAA 1174/4885SMN1; SMN2 4657/4885DGKA 1963/4885 |
| US-20110124736-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | FGF1, HDGF, FGF2 | NAAA 1174/4885SMN1; SMN2 4657/4885DGKA 1963/4885 |
| US-20030147823-A1 | Using a cyclopentane compound | HSD3B1, HSD3B2, CYP21A2 | NAAA 2836/4885SMN1; SMN2 4057/4885DGKA 3257/4885 |
| US-20080041749-A1 | Re-closable vessel system for repeat administration of a drug product and method | KDR, HCAR2, TBXA2R | NAAA 1174/4885SMN1; SMN2 3530/4885DGKA 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.